Published in Schizophr Res on November 30, 2000
Distinguishing between first-admission schizophreniform disorder and schizophrenia. Schizophr Res (2003) 0.81
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol (2004) 2.47
Childhood abuse in first-episode psychosis. Br J Psychiatry (1994) 2.17
A novel augmentation strategy for treating resistant major depression. Am J Psychiatry (2001) 2.05
Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry (1998) 2.00
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86
Extent of comorbidity between mental state and personality disorders. J Pers Disord (1997) 1.81
Unipolar mania reconsidered: evidence from an elderly cohort. Br J Psychiatry (1994) 1.57
Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand (2011) 1.52
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res (2003) 1.47
The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. J Clin Psychiatry (1999) 1.45
Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. Community Ment Health J (1995) 1.45
Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry (1992) 1.43
First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry (1998) 1.40
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res (2003) 1.29
MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry (1998) 1.28
Genome sequence of the obligate methanotroph Methylosinus trichosporium strain OB3b. J Bacteriol (2010) 1.24
Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry (1998) 1.20
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry (1997) 1.18
Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry (1999) 1.16
Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry (2000) 1.15
Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry (1998) 1.12
The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophr Res (1996) 1.10
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol (2001) 1.08
Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry (1988) 1.05
Functional impairment and cognition in bipolar disorder. Psychiatr Q (2000) 1.04
Heuristic models of comorbidity of axis I and axis II disorders. J Pers Disord (1997) 1.03
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry (1991) 1.02
Structural brain abnormalities in first-episode mania. Biol Psychiatry (1993) 1.02
A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry (1994) 1.01
Summer birth and the deficit syndrome of schizophrenia. Am J Psychiatry (1998) 1.01
Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord (2001) 1.01
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand (2014) 0.99
Comorbidity in psychosis at first hospitalization. Am J Psychiatry (1993) 0.99
Racial differences in the diagnosis of psychosis. Schizophr Res (1996) 0.99
Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry (1994) 0.98
Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry (1994) 0.96
Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord (2007) 0.96
DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. J Affect Disord (2013) 0.96
The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs. Schizophr Res (1996) 0.95
Maintenance treatment in bipolar disorder. Arch Gen Psychiatry (2000) 0.95
Telephone versus in-person clinical and health status assessment interviews in patients with bipolar disorder. Harv Rev Psychiatry (1998) 0.94
Clozapine in severe mood disorders. J Clin Psychiatry (1995) 0.93
Onset-age of bipolar disorders at six international sites. J Affect Disord (2009) 0.92
Predicting the course and outcome of bipolar disorder: a review. Eur Psychiatry (2010) 0.92
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry (1993) 0.92
Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J Affect Disord (2011) 0.90
Stigma and functioning in patients with bipolar disorder. J Affect Disord (2010) 0.89
Pre- and perinatal complications and risk for bipolar disorder: a retrospective study. J Affect Disord (1998) 0.89
Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder. J Affect Disord (2013) 0.89
Open trial of S-adenosylmethionine for treatment of depression. Am J Psychiatry (1984) 0.89
Transfer of psychiatric inpatients to a general hospital due to adverse drug reactions. Psychosomatics (1997) 0.88
Four cases of obstructive sleep apnea associated with treatment-resistant mania. J Clin Psychiatry (1991) 0.88
The Tridimensional Personality Questionnaire as a predictor of six-month outcome in first episode mania. Psychiatry Res (1993) 0.88
EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiatry (1996) 0.87
Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatr Scand Suppl (2004) 0.86
Comorbidity in mania at first hospitalization. Am J Psychiatry (1992) 0.86
Is clozapine a mood stabilizer? J Clin Psychiatry (1995) 0.86
Benzene: environmental partitioning and human exposure. Environ Res (1990) 0.85
An empirical study of psychosis in borderline personality disorder. Am J Psychiatry (1985) 0.84
Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J Clin Psychopharmacol (2001) 0.84
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol (2002) 0.84
Mania compared with unipolar depression in old age. Am J Psychiatry (1992) 0.84
The use of valproate in an elderly population with affective symptoms. J Clin Psychiatry (1996) 0.84
Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study. Actas Esp Psiquiatr (2007) 0.83
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord (2009) 0.83
Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry (1995) 0.82
Possible affective-state dependence of the Tridimensional Personality Questionnaire in first-episode psychosis. Psychiatry Res (1992) 0.82
MRI subcortical signal hyperintensities in mania at first hospitalization. Biol Psychiatry (1993) 0.82
Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry (1991) 0.82
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline? J Clin Psychiatry (1996) 0.81
Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America. J Clin Psychopharmacol (2001) 0.81
Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study. J Affect Disord (2010) 0.81
Cycling into depression from a first episode of mania: a case-comparison study. Am J Psychiatry (2001) 0.81
High risk of eosinophilia in women treated with clozapine. J Clin Psychiatry (1993) 0.81
Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv Rev Psychiatry (1997) 0.81
Psychopathology factors in first-episode affective and non-affective psychotic disorders. J Psychiatr Res (2006) 0.80
Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J Clin Psychopharmacol (1994) 0.80
Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry (1998) 0.80
Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry (1997) 0.79
Health care of physicians' children. Pediatrics (1989) 0.79
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine. J Clin Psychopharmacol (2002) 0.79
Prescribing trends of antidepressants in bipolar depression. J Clin Psychiatry (1995) 0.78
Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study. Pharmacopsychiatry (2009) 0.78
Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group. Schizophr Res (1994) 0.78
What makes a drug a primary mood stabilizer? Mol Psychiatry (2002) 0.77
Genome Sequence of the Obligate Gammaproteobacterial Methanotroph Methylomicrobium album Strain BG8. Genome Announc (2013) 0.77
Thyroid function tests in first-episode bipolar disorder manic and mixed types. Biol Psychiatry (1997) 0.77
Adult-type CML in childhood: case report and review. Am J Pediatr Hematol Oncol (1984) 0.77
Long-term response to carbamazepine: a retrospective study. J Clin Psychopharmacol (1988) 0.76
Use of olanzapine in dysphoric mania. J Affect Disord (2001) 0.76
Concurrent use of clozapine and valproate in affective and psychotic disorders. J Clin Psychiatry (1994) 0.76
Brief communication: pathological narcissism in bipolar disorder patients. J Pers Disord (1998) 0.76
Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry (2000) 0.76
Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993. J Affect Disord (1997) 0.76
In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005. Eur Psychiatry (2010) 0.76
Combined valproate or carbamazepine and electroconvulsive therapy. Ann Clin Psychiatry (1997) 0.75
Switching between clozapine and risperidone treatment. Can J Psychiatry (1997) 0.75